Paxlovid does not increase risk of COVID reinfection: study

Published Date: 16 Feb 2023

Although there are concerns that the use of Paxlovid increases the risk of COVID-19 returning, the results are clear.

Read Full News

Latest News

Workplace Heat Risk in Italy: A Growing Blind Spot

Italian workers remain poorly informed about heat risks, with many unable to recognize heatstroke or act quickly — a gap the WORKLIMATE project aims to close.

PARP Inhibitors for Prostate Cancer: 5 Things to Know

PARP inhibitors are reshaping the treatment landscape for metastatic prostate cancer, but who actually benefits, and how do we navigate the toxicity and testing gaps to use them wisely?

Cerebral Venous Sinus Thrombosis Following Meningitis in Man

A man develops delayed cerebral venous sinus thrombosis after pneumococcal meningitis despite apparent treatment success, highlighting persistent headache as a warning sign.

What’s Driving the Hormone Therapy Surge?

After more than two decades of conservative prescribing, data from Epic show a sharp increase in hormone therapy orders for women who may be experiencing perimenopause or menopause.

Autism Rates Surge Post-Pandemic in Female Patients

US autism diagnoses surged after 2020 in female patients but remained stable or declined in male patients, a new study shows.

Kids With Complexity May Miss Posthospital PCP Visits

Children with vs without medical complexity are less likely to complete primary care follow-up after hospitalization, and those who attend follow-up have a higher risk of being readmitted.

Todays Updates

Defibrotide Prophylaxis May Reduce SOS Risk After HSCT

A study evaluates whether defibrotide prophylaxis during HSCT reduces the risk for sinusoidal obstruction syndrome in children with relapsed or refractory B-ALL receiving prior inotuzumab.

Todays Updates

Defibrotide Prophylaxis May Reduce SOS Risk After HSCT

A study evaluates whether defibrotide prophylaxis during HSCT reduces the risk for sinusoidal obstruction syndrome in children with relapsed or refractory B-ALL receiving prior inotuzumab.

Latest News

Italian workers remain poorly informed about heat risks, with many unable to recognize heatstroke or act quickly — a gap the WORKLIMATE project aims to close.

PARP inhibitors are reshaping the treatment landscape for metastatic prostate cancer, but who actually benefits, and how do we navigate the toxicity and testing gaps to use them wisely?

A man develops delayed cerebral venous sinus thrombosis after pneumococcal meningitis despite apparent treatment success, highlighting persistent headache as a warning sign.

After more than two decades of conservative prescribing, data from Epic show a sharp increase in hormone therapy orders for women who may be experiencing perimenopause or menopause.

US autism diagnoses surged after 2020 in female patients but remained stable or declined in male patients, a new study shows.

Children with vs without medical complexity are less likely to complete primary care follow-up after hospitalization, and those who attend follow-up have a higher risk of being readmitted.

News All Time

Fewer Overseas Nurses Joining UK Register, NMC Data Show

International recruitment to the Nursing and Midwifery Council register nearly halved in 2025-2026, even as diversity and overall numbers hit new highs.

One Food, Every Meal – What Does This Do to the Gut?

With the mono diet, patients eat only one food. Dr Alicia Muratore explains the lack of data behind it and offers recommendations for talking to patients.

GLP-1s Slash Obesity-Related Cancer Risk

Prof David Kerr reviews a new study published in Annals of Oncology tracking how GLP-1 receptor agonists significantly slashed the short-term incidence of 13 tumor types.

FemTech’s Biggest Test: Can It Deliver on Its Promise?

Wearables and advanced algorithms are expanding FemTech beyond fertility tracking, but scientific validation, regulation, and privacy remain essential for clinical adoption.

US Adults Prefer Longer Antibiotic Courses

Many US adults prefer longer courses and rate them safer and more effective than shorter courses.

Bacterial Vaginosis Linked to Higher Risk for STIs

Women with bacterial vaginosis face substantially elevated odds of concurrent chlamydia, gonorrhea, trichomoniasis, and mycoplasma infections.

US Women Unsure When, How to Seek Perimenopause Treatment

The survey study finds prevalent uncertainty about perimenopause in US women; an expert says that’s because the diagnosis isn’t real.

Nightly Bladder Drainage May Help Boys After Valve Surgery

Overnight drainage of the bladder in boys who have undergone valve surgery may help reduce kidney swelling.

Uterine-Preserving Surgery May Up Prolapse Retreatment Risk

Women who underwent uterine-preserving surgery for apical pelvic organ prolapse have a higher risk for retreatment than those who underwent hysterectomy with apical suspension.

Fingertip Sweat Patch Tracks Levodopa Levels in PD

A power-free fingertip patch continuously monitors levodopa in sweat, with readings that closely correlate with gold-standard blood testing in healthy participants and those with Parkinson’s disease.

Three Cancer Drugs Advance Toward Broader EU Use

Enhertu, Piqray, and Trodelvy moved closer to broader EU indications after CHMP backed new first-line combinations and expanded biomarker-based use in breast cancer.

Older Adults Advised to Limit Anticholinergic Medicines

The review examined 17 studies, all at serious or critical risk of bias, and could not confirm or exclude a causal link to dementia.

Overheard in Medicine: Betting on Clinical Trials?

Overhead in Medicine is a Medscape digest that surfaces a few of the week's top posts from major medical subreddits.

How Green Are Prescriptions? New Data Offer Clues

Researchers provide one of the first estimates of the carbon footprint of primary care prescribing, offering data to support more environmentally sustainable medication use.

EMA Clears One Rare Brain Disease Therapy, Rejects Another

European regulators recommended a treatment for childhood cerebral adrenoleukodystrophy but refused one for Niemann-Pick disease type C.

GP Follow-Up Tied to Higher Cervical Surveillance Loss

Patients with cervical precancerous lesions followed by general practitioners showed higher rates of missed surveillance appointments than those monitored by gynecologists.

Recommended News For You

CAR-T Trial Raises Prospect of Preventing Myeloma in High-Risk Group

Cancer Patients Who Completed Medication Survey Received More Help From Pharmacists

A large study found that monolayers were superior in detecting cancer.

WHO releases new R&D landscape analyses highlighting gaps and inequities in cancer research

Adding Isatuximab to Standard Backbone Prolongs PFS in Myeloma

UK study evaluates effectiveness of cancer diagnosis pathway for patients with non-specific symptoms

Heavy Cannabis Use Tied to Increased Head and Neck Cancer Risk

Recommended Articles For You

Myeloproliferative Disorders: Causes, Symptoms and Treatment Options  

Potential of Device-Assisted Therapy in Non-Muscle-Invasive Bladder Cancer 

Amivantamab Plus Chemotherapy Outperforms Standard Care in Post-Osimertinib NSCLC 

Unraveling the Complexities of Embryonal Carcinoma: A New Hope for Treatment 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Weight loss and cancer; no brain tumor blood test; no cervical cancer after HPV vaccination.

2.

An inoperable locally advanced NSCLC trial dubbed "Practice Changing".

3.

The top three drugs for multiple myeloma treatment upfront are four.

4.

Increased Data Support Active Monitoring for Low-Risk Prostate Cancer.

5.

Snus Linked to Gingival Damage, Raising Safety Questions

1.

Emerging Insights in Hematology for Better Care

2.

Hepatocellular Carcinoma: Progress in Detection, Pathogenesis, and Treatment

3.

Reconstructive Tissue Engineering After Tumor Resection

4.

The Importance of Maintaining Normal Calcium Levels in Your Body 

5.

Immunotherapy Breakthroughs: Transforming Cancer Care Across All Oncology Fields

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma

2.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV

3.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII

4.

Exploring the Hospitalization Burden in Refractory and Relapsed ALL

5.

The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot